Related references
Note: Only part of the references are listed.Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study
Ludovic Drouet et al.
AMERICAN HEART JOURNAL (2009)
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents The Acute Catheterization and Urgent Intervention Triage Strategy Trial
Jiro Aoki et al.
CIRCULATION (2009)
Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice
Tracy Y. Wang et al.
CIRCULATION (2009)
Bleeding in Patients Undergoing Percutaneous Coronary Intervention The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry
Sameer K. Mehta et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
George Dangas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout mice
Subrata Chakrabarti et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
Marc S. Sabatine et al.
LANCET (2009)
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
Roxana Mehran et al.
LANCET (2009)
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention
Spencer B. King et al.
CIRCULATION (2008)
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Mark Y. Chan et al.
CIRCULATION (2008)
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2008)
Influence of Timing of Clopidogrel Treatment on the Efficacy and Safety of Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention An Analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
A. Michael Lincoff et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
The CIAO (coronary interventions antiplatelet-based only) study
Eugenio Stabile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy
Harvey D. White et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention quantitative review of randomized trials
Raphaelle Dumaine et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Efficacy and safety of fondaparinux versus Enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
Shamir R. Mehta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis)
C. Michael Gibson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial
C. Michael Gibson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention - A single-institution experience
Mandeep Singh et al.
CIRCULATION (2007)
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention - The SEPIA-PCI trial
Marc Cohen et al.
CIRCULATION (2007)
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
Sunil V. Rao et al.
EUROPEAN HEART JOURNAL (2007)
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity
Christopher K. Dyke et al.
CIRCULATION (2006)
Bivalirudin for patients with acute coronary syndromes
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: Enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes
Marc Cohen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
Gilles Montalescot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment -: The ISAR-REACT 2 randomized trial
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention - Arixtra study in percutaneous coronary intervention: A randomized evaluation (ASPIRE) pilot trial
SR Mehta et al.
CIRCULATION (2005)
Reliable anticoagulation with Enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study
JL Martin et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2004)
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
A Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Relationship between activated clotting time and ischemic or hemorrhagic complications - Analysis of 4 recent randomized clinical trials of percutaneous coronary intervention
SJ Brener et al.
CIRCULATION (2004)
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization - REPLACE-2 randomized trial
AM Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin
G Montalescot et al.
CIRCULATION (2004)
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial
AM Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Share Paper
